Kaplan-Meier analysis showed that patients whose tumours express high levels of DCN or HSP90B1 in the malignant epithelium have significantly lower OS and DFS compared to patients with lower expression of either marker

July 4, 2017

icals within the cells that most often will be neutralized by get Salidroside intracellular antioxidant machinery without affecting the viability of the cells. But the untreated cells showed no evidence for cell death under the same imaging condition. The massive cell death observed in treated samples with continuous excitation may be due to the neutralization of antioxidant machinery of the cells by FAE promoting ROS mediated fast cell death. Consistent with this notion, we have observed increased intracellular ROS in treated cells and the pretreatment of cells with the anti oxidant NAC reduced chromatin condensation induced by FAE. Earlier studies suggest that intracellular ROS contribute for Bax activation during apoptotic cell death. In addition, FAE could kill most of the breast cancer cell lines through the loss of mitochondrial membrane potential and condensation of chromatin. However, the two normal cells, endothelial cells and mammary epithelial cells were relatively less susceptible to mitochondrial membrane potential loss and chromatin condensation induced by FAE. All these data suggest the potential of FAE in inhibiting the proliferation and enhancing selective death of cancer cells without inducing cell death in non-tumorigenic cell line as well as normal primary cells. Additionally, we have shown that FAE possess strong photosensitizing activity involving accelerated mitochondrial transmembrane potential loss. Our studies using defined cellular models of apoptosis like Bax EGFP and caspase sensor cell lines also revealed that Bax mediated mitochondrial transmembrane potential loss contributed for the apoptotic cell death. Silencing of Bax in MCF-7 cells again supported the essential requirement of Bax in mediating FAE induced cell death. The cancer cell specific apoptotic activity with moderate toxicity to normal cells and photosensitizing activity of FAE indicate that the plant extract could be a potential source for possible candidate drug identification. Photosensitizing agents are emerging as potential anti-cancer therapeutic agents to ensure the complete elimination of chemo resistant and radiation resistant cancers. Further studies are needed to purify the photosensitizing component of FAE. To our knowledge, the results showed for the first PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22200994 time that FAE induced apoptosis in breast adenocarcinoma cell line and also it possessed strong photosensitizing effect. Based on the results obtained, we have proposed a mechanism for the FAE induced apoptosis that involved ROS mediated Bax activation leading to mitochondrial potential loss followed by caspase activation. We conclude that, FAE inhibited the growth of MCF-7 human breast carcinoma cells and Bax induced mitochondria mediated apoptosis. FAE also possess strong photosensitizing effect on cancer cells that was mediated through rapid mitochondrial transmembrane potential collapse and partial Caspase activation. Further pre-clinical animal studies using purified compound from this extract might help in identifying drug candidates that could replicate the biological activities of FAE. Materials and Methods Preparation of FAE and Phytochemical Analysis Air-dried powdered leaves were extracted using a Soxhlet apparatus successively with hexane, chloroform, acetone and methanol for 20 h in each solvent and then the extract was filtered and evaporated under reduced pressure. The final concentrate was recovered and dissolved in DMSO or stored in 280uC until use. Acetone extract showed minimum